Evolution of Coagulation Activity in Non Valvular Atrial Fibrillation Patients Under Apixaban
NCT03136510
·
clinicaltrials.gov ↗
NA
Phase
TERMINATED
Status
12
Enrollment
OTHER
Sponsor class
Stopped
not enough patients
Conditions
Coagulation Disorder
Non Valvular Atrial Fibrillation
Interventions
DRUG:
Apixaban 5 mg
Sponsor
Hopital Lariboisière